Solid Biosciences (SLDB) Net Margin (2022 - 2024)
Historic Net Margin for Solid Biosciences (SLDB) over the last 3 years, with Q4 2024 value amounting to 50728.0%.
- Solid Biosciences' Net Margin changed N/A to 50728.0% in Q4 2024 from the same period last year, while for Dec 2024 it was 35470.29%, marking a year-over-year decrease of 447859000.0%. This contributed to the annual value of 35470.29% for FY2024, which is N/A changed from last year.
- According to the latest figures from Q4 2024, Solid Biosciences' Net Margin is 50728.0%.
- Over the past 5 years, Solid Biosciences' Net Margin peaked at 50728.0% during Q4 2024, and registered a low of 406.69% during Q2 2022.
- Moreover, its 3-year median value for Net Margin was 27173.88% (2024), whereas its average is 28319.87%.
- Over the last 5 years, Solid Biosciences' Net Margin had its largest YoY gain of 5009700bps in 2024, and its largest YoY loss of 5009700bps in 2024.
- Quarter analysis of 3 years shows Solid Biosciences' Net Margin stood at 406.69% in 2022, then soared by 6268bps to 25084.3% in 2023, then soared by 102bps to 50728.0% in 2024.
- Its last three reported values are 50728.0% in Q4 2024, 40165.85% for Q3 2024, and 28762.5% during Q2 2024.